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Abstract
Intravascular large B-cell lymphoma is a rare and aggressive EBV-negative large B-cell lymphoma with a dismal outcome. 
Here, we describe the case of a 76-year-old HIV-positive patient with an acute presentation of systemic symptoms and 
rapidly fatal outcome. Autopsy revealed a disseminated large B-cell lymphoma with an intravascular distribution involving 
the liver, lymph nodes, spleen, and bone marrow and associated to fibrin thrombi in hepatic capillary haemangiomas. The 
neoplastic B cells (CD79a + / − , CD20 + / − , CD30 + , MUM1 + , PD-L1 +) showed a Hodgkin and Reed-Sternberg-like 
morphology and were EBV-positive with a latency type II (LMP1 + , EBNA2-). Haemophagocytosis was documented in the 
bone marrow and lymph nodes. This case illustrates the diagnostic challenges of large B-cell lymphoma with intravascular 
presentation. We found only five other cases of EBV-positive large B-cell lymphoma with an intravascular presentation in the 
literature, three of which had an underlying immunodeficiency adding to the broad spectrum of EBV-associated lymphoma 
in the setting of immunosuppression.
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Introduction
Intravascular large B-cell lymphoma (IVLBCL) is a rare 
and aggressive B-cell neoplasia that affects mainly elderly 
patients, usually disseminated at diagnosis and character-
ized by the selective growth of neoplastic cells within the 
lumina of vessels, particularly the capillaries [1]. The dis-
ease usually affects individuals without underlying immu-
nodeficiency and is Epstein-Barr virus (EBV)-negative [2]. 
Three variants of clinical presentation are currently recog-
nized as follows: (1) a classical form (usually encountered 
in Western countries), which shows organ-related symptoms 
with frequent central nervous system and cutaneous involve-
ment; (2) a haemophagocytic syndrome (HPS)-associated 
form (Asian variant) characterized by fever, hepatosple-
nomegaly, pancytopenia, and multiorgan failure; and (3) a 
cutaneous variant, associated with better outcome [2]. Here, 
we report a 76-year-old human immunodeficiency virus 
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(HIV)-positive patient with a post-mortem diagnosis of 
EBV-positive large B-cell lymphoma with an unusual intra-
vascular presentation. Interestingly, tumour cells invaded the 
lumina of hepatic capillary haemangiomas. We found five 
other cases of EBV-positive large B-cell lymphoma with an 
intravascular location in the literature. Collectively, these 
Virchows Archiv 
1 3
case reports emphasize the broad spectrum of EBV-associ-
ated lymphoproliferative disorders and a possible oncogenic 
role of EBV and immunosuppression in these rare instances.
Case presentation
The patient was a 76-year-old Caucasian male known for 
HIV infection diagnosis 2 years ago in the Caribbean who 
started combined anti-retroviral therapy at diagnosis. The 
patient with recent onset of fatigue and 30 kg weight loss 
was admitted to the emergency department with altered gen-
eral condition and fever (38 °C). He reported having inter-
rupted the treatment for a couple of months. Abdominal 
sonography revealed hepatomegaly with some hypodense 
foci measuring up to 2 cm, consistent with hepatic haeman-
giomas. No lesion suspicious of neoplasia was observed. At 
admission, laboratory tests showed low CD4 + T-cell count, 
83 cells/mm3; HIV viral load, 4.1 ×  103 copies/ml; Hb 92 g/l; 
leukocytes 4.4 ×  109/L with lymphopenia at 0.6 ×  109/L; 
platelets 113 ×  109/L; ferritin 8.033 µg/l (normal values: 
24 to 336 µg/l); fibrinogen <1.5 g/L (2.0 to 4.0 g/L) and 
normal values of triglycerides (< 150 mg/dL). A high EBV 
viral load (400.000 copies/mL) suggested the possibility of a 
HPS, although in the course of the hospitalization only four 
of five criteria required for the diagnosis were met (fever, 
anaemia and thrombocytopenia, hypofibrinogenemia and 
high ferritin levels). Repeated haemocultures and multiple 
serologies remained negative. Despite antiretroviral therapy, 
broad-spectrum antibiotic and antifungal therapy, patient 
developed acute liver and renal failure, refractory vasoplegic 
shock, and died 5 days after admission.
The autopsy showed pericardial and pleural effusions, 
haemorrhagic ascites, splenomegaly (530 g), and hepato-
megaly (2000  g). Two haemorrhagic-appearing lesions 
(2.4 and 3 cm) in the liver consistent with haemangio-
mas suspected by imaging studies were found. Small 
intra-abdominal and supra-diaphragmatic lymph nodes 
(< 1 cm) were identified.
Histologically, the liver lesions were typical of capil-
lary haemangiomas and consisted of large vascular spaces 
lined by unremarkable endothelium. The lumina contained 
aggregates of large, atypical tumour cells with ample and 
pale cytoplasm, irregular nuclear contours, vesicular chro-
matin, some with prominent nucleoli or Reed-Sternberg-
like morphology (Fig. 1a–c), often admixed with fibrin 
thrombi. The atypical large cells were partially positive for 
CD20 (Fig. 1d), and CD79a, strongly positive for CD30 
(Fig. 1e) and PD-L1 (Fig. 1f) and partially expressed MUM1 
(Fig. 1g). CD10, BCL6, CD138, LANA1 (HHV8), CD5, and 
MYC were negative. KI-67 proliferation index was around 
60%. Virtually all tumour cells were positive for EBV by 
in situ hybridization with EBER probes (Fig. 1h) and by 
immunohistochemistry were LMP1-positive (Fig. 1i) and 
EBNA2-negative. Intravascular EBV-positive tumour cells 
were observed in the hepatic sinusoids outside the hepatic 
hemangioma (Fig.  1j), lymph nodes sinuses and small 
and medium-sized blood vessels (Fig.  1k), spleen, and 
bone marrow. Numerous histiocytes with abundant cyto-
plasm and ingested red blood cell, erythroid progenitors, 
or lymphocytes (haemophagocytosis) were identified in the 
lymph nodes’ blood vessels (Fig. 1k), liver, and bone mar-
row (Fig. 1l, left panel) highlighted by CD68 (Fig. 1l, right 
panel). No lesions of Kaposi’s sarcoma were observed. FISH 
studies using break-apart probes did not detect rearrange-
ments of BCL2, BCL6, or MYC. High-throughput sequenc-
ing analysis using a customized panel of 54 genes relevant 
to the biology of mature B-cell lymphoma (Supplemental 
Information) did not detect mutations in MYD88, CD79a, 
or EZH2, genes recurrently altered in IVLBCL [2]. Multi-
ple mutations suggestive of aberrant somatic hypermutation 
were detected at low variant allele frequency (3%) in the of 
SOCS1 exon 2.
Discussion
Here, we report a case of an EBV-positive large B-cell lym-
phoma with an unusual intravascular presentation, which 
manifested as a clinically fulminant disease in a deeply 
immunosuppressed patient with uncontrolled HIV infection. 
Similar to typical IVLBCL, the diagnosis was made post-
mortem, highlighting the difficulties in reaching a timely 
diagnosis in these patients [1]. The HPS suspected clinically 
was convincingly confirmed by the histological findings at 
autopsy, and other characteristic findings of HPS-associated 
variant of IVLBCL were also observed [2], i.e., bone mar-
row involvement, fever, hepatosplenomegaly, and thrombo-
cytopenia, which were present in our patient. Nevertheless, 
the HPS-associated variant of IVLBCL has been reported 
Fig. 1  Histopathologic features of liver (a–j), lymph nodes (k), and 
bone marrow (l). Liver haemangioma showed aggregates of large 
tumour cells admixed to fibrin thrombi in the vascular lumina (a). 
The lymphoma cells were large pleomorphic sometimes resembling 
Reed-Sternberg cells (b, arrows, and c). The tumour cells were par-
tially positive for CD20 (d), strongly positive for CD30 (e), PD-L1 
(clone SP263) (f), and MUM1 (g). Neoplastic cells were positive for 
EBV (EBER-ISH) (h) and LMP1 (i). Atypical EBV-positive large 
tumour cells were identified in hepatic sinusoids (j, arrows; EBER-
ISH, inset, arrows). Tumour cells were also observed colonizing 
lymph node’s blood vessels (k, blue arrow), with LMP1-expression 
(k, inset, blue arrows). Lymph node’s blood vessels (k) and bone 
marrow (l, left panel) comprised many histiocytes with engulfed red 
blood cells or nucleated cells (red arrows). CD68 (clone PG-M1) 
immunostaining highlights haemophagocytic histiocytes (l, right 
panel, red arrow). Original magnifications: a × 100, b, d, e, f, g, h, i, 




almost exclusively in Asian patients without associated 
immunosuppression or EBV infection [2, 3]. Therefore, it 
can be reasonably suggested that EBV infection may have 
played a role in the development of florid HPS in our patient.
We identified five other cases of EBV-positive large 
B-cell lymphoma with an unusual intravascular presenta-
tion reported in the literature, whose clinicopathological 
characteristics are shown in Table 1 [4–8]. These occurred 
in four men and one woman at a median age of 57 years 
(range 42–65 years). The four patients with documented eth-
nicity were Asian, in contrast to the Western origin of our 
case. Interestingly, three of the five patients had underlying 
immunosuppression (HIV in one case, immunosuppressive 
medication for autoimmune diseases in two cases) and local-
ized disease was reported in three patients. With the excep-
tion of one case involving Kaposi’s sarcoma, EBV-positive 
neoplastic cells showed expression of B-cell markers with a 
non-CGB phenotype (CD10 − , MUM1 + , and BCL6 − / +), 
as our case. Three patients died between 1 and 12 months 
after diagnosis, one with HPS. Of note, the case reported in 
the HIV-positive patient involving vascular lumina of Kaposi 
sarcoma had a plasmablastic immunophenotype but was not 
tested for HHV8. In that peculiar setting, however, coinfec-
tion of the neoplastic B cells with HHV8 cannot be excluded.
To this regard, there are few case reports of HHV8-posi-
tive large B-cell lymphoma with intravascular presentation, 
all occurring in immunosuppressed patients (HIV and organ 
transplantation) [9–15]. Coexistence of HHV8-positive 
large B-cell lymphoma with intravascular presentation with 
Kaposi sarcoma, both disseminated and limited to the skin 
were described frequently in those cases, as well as co-infec-
tion of tumour cells by EBV (62%). Those cases showed a 
plasmablastic morphology and immunophenotype (CD20-, 
MUM1 +). Diagnosis was made at post-mortem examination 
and all patients rapidly succumbed 2 months or less after of 
admission to the hospital. Interestingly, cases of polyclonal 
HHV8-positive circulating plasmablastic cells IgM λ have 
been described in HIV-positive patients and severe symp-
toms of muticentric Castleman disease, which may mimick 
plasmablastic leukemia/lymphoma [16].
The fact that EBV and/or HHV8-positive large B-cell 
lymphoma with intravascular presentation show varied 
clinical and pathological presentations, heterogenous out-
come and occur in association with immunosuppresion, sug-
gests that these cases are distinct from IVLBCL and rather 
represent virus-associated large B-cell lymphoma with an 
unusual intravascular location. Table 2 summarizes the main 
clinicopathological features of IVLBCL and the virus-asso-
ciated large B-cells lymphoma with unusual intravascular 
location.
Other distinctive morphological features in our case 
were the markedly pleomorphic cytomorphology includ-
ing Reed-Sternberg-like cells, and the immunophenotype 
characterized by an attenuated B-cell program, and strong 
CD30 and PD-L1 expression. To this regard, rare cases 
of EBV-positive, HHV8-positive large B-cell lymphoma 
with Hodgkin/Reed-Sternberg-like morphology have been 
reported, interestingly in HIV-negative patients, but not 
with an intravascular distribution [9, 17].
This case represents the first report of an EBV-positive 
large B-cell lymphoma colonizing hepatic haemangiomas. 
Interestingly, the lymphoma cells were mostly present in 
association with fibrinous thrombi partially filling the 
large angiomatous spaces. On a purely histopathological 
basis, these findings are reminiscent of fibrin-associated 
diffuse large B-cell lymphoma [1]. In this rare form of 
large B-cell lymphoma, EBV-positive tumour cells show 
a latency III program and do not form tumour masses [1]. 
This B-cell proliferation develops within fibrinous deposits 
in the walls of pseudocysts, in the cardiovascular system, 
in cavities, in association with prostheses, or in haemato-
mas [1]. However, in contrast to fibrin-associated diffuse 
large B-cell lymphoma, our patient presented a profound 
immunosuppression with a disseminated disease, an EBV-
associated HPS and an aggressive clinical course, sug-
gesting that viral oncogenic mechanisms, including latent 
protein expression (such as LMP1), were determinant for 
the pathogenesis and clinical course of the disease.
In conclusion, large B-cell lymphoma with intravascular 
presentation, including IVLBCL, remains a diagnostic and 
therapeutic challenge due to nonspecific and acute clinical 
presentation, frequently hindering an early and accurate 
diagnosis. Those cases associated with viral infection, such 
as EBV and/or HHV8, present distinct clinical-pathologi-
cal features and develop almost invariably in the setting of 
immunosuppression. These findings suggest they correspond 
to an unusual presentation of immunodeficiency-associated 
B-cell lymphoproliferative disorders, expanding the spec-
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